IDYA
#1655
IDEAYA Biosciences, Inc. - Common Stock
36.7 4 USD
0.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.25%
Changement Mensuel
+19.36%
Evolution sur 6 mois
+4.97%
Changement Annuel
+12.77%
Clôture Précédente
36.6 5
Open
36.7 4
Low
36.7 4
High
36.7 4
Volume
76
Financials
- Market Capitalization 3.23 B
- Employee 145
- Founded 2015
- CEO N/A
- Website www.ideayabio.com
- Headquarter Delaware, United States
- FIGI BBG00CTZ4D83
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.22
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1618 |  DYN Dyne Therapeutics, Inc. - Common Stock | 23.99 USD | +0.88% | +1.01% | +30.88% | +2.48% | 3.43 B USD | ||
| 1650 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 53.16 USD | +2.76% | +4.38% | +24.94% | +157.31% | 3.24 B USD | ||
| 1664 |  BEAM Beam Therapeutics Inc. - Common Stock | 30.84 USD | -0.16% | -15.81% | -0.68% | +53.28% | 3.17 B USD | ||
| 1680 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 31.71 USD | -1.00% | -8.64% | +26.39% | +15.90% | 3.12 B USD |